Windlas Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

10.46

10.90

6.41

6.41

6.41

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

392.20

384.23

192.58

210.07

187.61

Loan funds

Secured loans

0.44

6.12

30.24

22.16

22.89

Unsecured loans

-

-

-

-

-

Total

403.11

401.25

229.23

238.64

216.91

Uses of funds

Fixed assets

Gross block

187.61

158.73

152.73

139.50

124.80

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

78.20

67.54

56.79

71.07

62.87

Net block

109.41

91.18

95.94

68.43

61.93

Capital work-in-progress

14.78

8.01

0.04

-

4.58

Investments

106.55

64.86

23.18

120.98

120.98

Net current assets

Current assets, loans & advances

298.28

326.97

176.84

154.40

109.52

Less : current liabilities & provisions

125.90

89.78

66.77

105.16

80.10

Total net current assets

172.38

237.19

110.07

49.23

29.43

Miscellaneous expenses not written

-

-

-

-

-

Total

403.11

401.25

229.23

238.64

216.91

Notes:

Book value of unquoted investments

0.03

64.86

0.03

104.69

104.69

Market value of quoted investments

106.51

-

23.14

22.19

20.90

Contingent liabilities

14.11

3.25

-

-

0.30

Number of equity sharesoutstanding (Lacs)

209.27

217.94

64.11

64.11

64.11